Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TQ0256 |
FGFR4-IN-1
|
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FGFR4-IN-1 是一种 FGFR4 抑制剂 (IC50:0.7 nM)。 | |||
T11280 |
FGFR4-IN-4
|
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FGFR4-IN-4 is a FGFR4 inhibitor with anti-tumor activity. | |||
T37425 |
FGFR4-IN-5
FGFR4-IN-5 |
||
FGFR4-IN-5, a covalent FGFR4 inhibitor, demonstrates potency and selectivity with an IC50 value of 6.5 nM. Exhibiting significant in vivo anti-tumor activity, it is applicable for research in hepatocellular carcinoma [1]. | |||
T62522 | FGFR-IN-4 | ||
FGFR-IN-4 是一种 FGFR 的有效抑制剂。其中成纤维细胞生长因子受体 (FGFR) 是一种与成纤维细胞生长因子配体结合的酪氨酸激酶受体。FGFR-IN-4 具有潜力癌症疾病的研究。 | |||
T27319 |
FIIN-4
FIIN4 |
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FIIN-4 是 FGFR 的共价抑制剂,可用于转移性乳腺癌的研究。 | |||
T79880 |
FGFR4-IN-16
|
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FGFR4-IN-16 (CY-15-2)为FGFR-4选择性共价抑制剂,适用于癌症研究领域。 | |||
T64125 | FGFR-IN-8 | ||
FGFR-IN-8 一种高效的、口服具有活力的 FGFR 抑制剂,可抑制野生型和突变型 FGFR。 FGFR-IN-8 能够作用于 FGFR1 (IC50<0.5 nM)、V564F-FGFR2 (IC5016: 189.1 nM)、N549H-FGFR2 (IC50<0.5 nM)、V555M-FGFR3 (IC50: 22.6 nM)、FGFR3 (IC50<0.5 nM) 和 FGFR 4 (IC50: 7.30 nM)。FGFR-IN-8 能够诱导癌细胞凋亡(apoptosis),表现出抗癌效果。 |